News by Subject
News by Disease
News by Date
Post Your News
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
US & Canada
Post an Event
News | News By Subject | News by Disease |
News By Date | Search News
Novasep Appoints Nadege Laborde As President Of Its Industrial Biotech Business Unit
11/19/2013 10:45:54 AM
Pompey, France, November 19, 2013 - Novasep, a leading supplier of manufacturing solutions to the life sciences industry, today announces the appointment of Nadege Laborde as the new president of its Industrial Biotech business unit. This internal promotion strengthens the business unit and is a key addition to the Executive Committee (COMEX). The nomination recognizes and rewards all of the commitment and skill that Nadege has demonstrated within the business.
Nadege joined Novasep in 2000 after qualifying as an engineer from Ecole Centrale, Paris. She started at Novasep as a project manager and expanded her responsibilities as an engineering manager in the US and Asia. Since 2009 she has headed the system engineering and construction department and driven her multicultural team in France and China towards achieving both operational excellence and customer satisfaction. Nadege has implemented strategic cost optimizations and innovated across both industrial process design and the worldwide supply chain enabling an average double-digit growth of industrial biotech unit sales over the last four years.
Nadege Laborde will expand Novasep’s market reach into new geographical territories.
“I am convinced Novasep as a group has a strong growth potential. I’m eager to support our continued development in all areas,” says Nadege.
“I’m very pleased to welcome Nadege Laborde as the new president of the industrial biotech business unit. Her nomination is another milestone in Novasep’s senior management recruitment program,” says Michel Spagnol, CEO. “With a passion for industrial processes, Nadege has delivered consistent customer results over the last decade. She has been instrumental in maintaining and developing our world leadership across a broad range of markets and applications.”
Novasep is on track for continued growth and expansion and poised to continue delivering value-added solutions to global customers.
Michel says: “With the scientific expertise of its teams, the Novasep industrial biotech business unit has a proven ability to innovate, resulting in a uniquely diversified offer and a wide range of client references in traditional markets. I firmly believe our business unit has the capacity to accelerate its growth and to generate increasing sales and profitability.”
About Novasep’s Industrial Biotech Business Unit
The business unit sells purification systems and turnkey process lines with a performance guarantee for the processing of food and functional ingredients, large scale fermentation products and bio-based chemicals. Its offering includes process design, engineering, supply and commissioning, as well as process development services, pilot plants and customer service for technical support, spare parts and consumables.
Novasep is a global provider of cost-effective and sustainable solutions to produce active molecules at the required purity. Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as bio-sourced chemicals and bio-industries.
To download a photograph of Nadege Laborde: http://www.ala.com/article.php?id=308
ANDREW LLOYD & ASSOCIATES
Tel UK: +44 1273 675100
Tel France: +33 1 56 54 07 00
Tel US: +1 617 517 0146
INTERNATIONAL TECHNOLOGY MARKETS, STRATEGY & COMMUNICATION
Help employers find you! Check out all the jobs and post your resume.